Anthos Therapeutics Launches Second Phase 3 Clinical Trial of Its Dual-acting Factor XI Inhibitor, Abelacimab
Abelacimab is the only Factor XI inhibitor currently being evaluated in Phase 3 trials The…
News
Frontier Medicines Announces the Appointment of Seasoned Legal Executive Mark Dizon, J.D., as General Counsel
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…
TG Therapeutics Announces Results from the ULTIMATE I & II Phase 3 Trials of Investigational Ublituximab in RMS Published in The New England Journal of Medicine
Ublituximab is an investigational targeted B-cell therapy that shows superior efficacy when compared with teriflunomide,…
OpGen Launches Ares Sequencing Services in the U.S. from its Rockville, Maryland Laboratory
Expanding services and offerings to the infectious disease community throughout the U.S. provides revenue growth…
Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection
– Investigational New Drug Application for CNTY-101, a CAR-iNK product candidate targeting CD19 for B-cell malignancies,…
Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
Patient denied testing for weeks due to risk of physician infection & non-MSM status Amerimmune…
Iovance Biotherapeutics Initiates Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma
First TIL Therapy BLA Submission Initiated with U.S. Food and Drug Administration Complete BLA Submission…
Clearside Biomedical to Present at the Ophthalmology Futures Retina Forum 2022
ALPHARETTA, Ga., Aug. 25, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Pandemic Influenza Preparedness
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Aclaris Therapeutics Announces Patent License Agreement with Lilly for Alopecia Areata
WAYNE, Pa., Aug. 25, 2022 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
ibex Honduras Continues to Grow; Hiring 500 New Agents
Award-Winning BPO Offers Unmatched Employee Experience, Benefits, and Career Opportunities ibex Honduras Continues to Grow;…
Exterro Launches FTK® Suite 7.6, Introducing Mobile Parsing, Automation Capabilities, and Industry-First Remote Endpoint Triage
Exterro FTK Gets Evidence Into the Hands of Investigators Faster Than Ever PORTLAND, Ore., Aug….
Kiteworks-enabled Private Content Networks Simplify and Deliver Rapid CMMC 2.0 Compliance
Over 300,000 DoD contractors and subcontractors can address almost 90% of CMMC 2.0 Level 2…
SimpleNexus to Power User-Friendly Mobile Homebuying Experience for Approved Mortgage
Locally owned Indiana lender will leverage SimpleNexus’ homeownership platform as a competitive advantage with tech-savvy…
VitalHub Corp. Announces Intention to Make a Normal Course Issuer Bid
Toronto, Ontario–(Newsfile Corp. – August 25, 2022) – VITALHUB CORP. (TSX: VHI) (the “Company” or…
Sonim Technologies Announces XP3plus Ultra-Rugged Flip Phone Award with Major U.S. Carrier
Popular, Affordable Flip Phone Delivers Simple, Fast and Reliable Communications Austin, Texas–(Newsfile Corp. – August…
Awakn Life Sciences Signs Agreement with a Leading Drug Development Company to Deepen IP Moat for Its Lead Program
Agreement Provides 12-Month Exclusive Period to Agree in-Licensing Deal for Proprietary Formulation of Ketamine Toronto,…
Reklaim Announces Q2-2022 Financial Results with Revenues Up 277% Year-Over-Year and 65% Quarter-Over-Quarter
Revenue momentum continues to build; year-to-date revenue up 216% over prior year, and the number…
Hitachi, Ltd. and Hitachi Energy are rising to the challenge of advancing a sustainable energy future for all
TOKYO and ZURICH, Aug 25, 2022 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501) and…
SKYX Platforms to Introduce its Upcoming Gen-1 Game-Changing Platform Technology Video Demo
MIAMI, FL, Aug 25, 2022 – (ACN Newswire) – SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a “Sky…